Stay updated on Onasemnogene for SMA: Intrathecal Clinical Trial
Sign up to get notified when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.

Latest updates to the Onasemnogene for SMA: Intrathecal Clinical Trial page
- Check3 days agoChange DetectedA banner announces an NIH website terminology transition, noting that both “Artificial Intelligence” and “Super Intelligence” may appear in NIH content.SummaryDifference1%

- Check10 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check37 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the expected content with an error screen. The visible header and footer indicate an access issue rather than new or updated trial information.SummaryDifference19%

- Check58 days agoChange DetectedA new revision number was published (v3.6.6) replacing the previous one (v3.6.5), indicating an updated version of the page.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4, signaling an updated release of the page. This reflects a new version of the page's template or scripts rather than changes to the study data.SummaryDifference0.0%

Stay in the know with updates to Onasemnogene for SMA: Intrathecal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.